Skip to main content

Table 4 Total scores in the limb salvage group

From: Cross-cultural adaptation and validation of a self-reporting tool to assess health-related quality of life for Egyptians with extremity bone sarcomas in childhood or adolescence

 

n

LE- Modifieda

LE- Originalb

n

UE- Modifieda

UE- originalb

Median (IQR)

P-value

Median (IQR)

P-value

Median (IQR)

P-value

Median (IQR)

P-value

Overallc

172

69.2 (20.5)

 

73.0 (21.7)

 

45

73.1 (20.0)

 

76.1 (22.3)

 

Age group

  

0.124

 

0.04*

  

0.239

 

0.492

 Pediatric

120

68.5 (20.6)

 

70.7 (23.9)

 

10

80.3 (31.7)

 

81.0 (30.9)

 

 Adult

52

72.6 (19.0)

 

77.0 (19.4)

 

35

73.0 (17.3)

 

76.1 (19.1)

 

Gender

  

0.809

 

0.38

  

0.175

 

0.383

 Male

86

69.3 (22.3)

 

71.8 (24.5)

 

19

75.0 (23.8)

 

81.5 (23.1)

 

 Female

86

69.1 (16.3)

 

73.1 (24.5)

 

26

72.7 (22.8)

 

75.9 (29.3)

 

Diagnosis

  

0.077

 

0.204

  

0.99

 

1

 Osteosarcoma

120

67.3 (21.2)

 

71.2 (24.3)

 

32

73.8 (19.7)

 

76.5 (20.4)

 

 Ewing sarcoma

52

72.9 (15.9)

 

74.6 (19.3)

 

13

72.3 (25.8)

 

76.1 (28.2)

 

Tumor locationd

  

0.002*

 

0.007*

  

0.427

 

0.293

 Tibia

41

61.5 (21.7)

 

65.4 (26.1)

      

 Femur

112

70.9 (18.1)

 

73.2 (20.6)

      

 Fibula

17

73.5 (14.7)

 

76.0 (13.9)

      

 Humerus

     

27

70.2 (16.2)

 

72.6 (26.6)

 

 Scapula

     

11

74.5 (19.1)

 

77.1 (22.7)

 

≥ 1 year from surgery

  

0.001*

 

 < 0.001*

  

0.561

 

0.819

 No

32

63.1 (27.9)

 

63.0 (28.4)

 

10

75.0 (17.3)

 

72.8 (18.4)

 

 Yes

140

70.8 (19.4)

 

74.1 (19.9)

 

35

73.0 (22.0)

 

76.9 (29.2)

 

Limb salvaged

  

0.308

 

0.17

  

0.506

 

0.369

 Prosthesis

111

69.1 (19.4)

 

72.9 (19.8)

 

10

72.2 (12.4)

 

74.4 (19.3)

 

 VFG

43

68.1 (24.9)

 

72.2 (26.4)

 

10

69.0 (35.7)

 

74.0 (36.5)

 

 Fibulectomy

16

73.2 (12.5)

 

75.5 (12.6)

      

 ECI

     

11

74.5 (19.1)

 

77.1 (22.7)

 

Chemotherapy

  

0.047*

 

0.023*

  

0.93

 

0.428

 On therapye

20

64.9 (24.7)

 

63.6 (26.8)

  

68.4 (18.0)

 

69.2 (19.7)

 

 Ended therapy

152

70.2 (21.5)

 

73.2 (22.6)

  

73.8 (20.9)

 

77.0 (23.0)

 
  1. aModified versions of pTESS/TESS
  2. bOriginal versions of pTESS/TESS
  3. cTemporary spacers of lower extremity were excluded
  4. dTalus and calcaneous (n=2) were excluded from this comparison
  5. eThose who ended treatment in less than one month were included in “on therapy” group